Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
  • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
  • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
  • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids

Definitions

• R is hydrogen, lower alkyl, aralkyl, a salt forming ion or the group
• R is lower alkyl, cyclo-lower alkyl, unsaturated cyclolower alkyl, aryl, aralkyl or a heterocyclic group
• R is hydrogen, lower alkyl or aryl
• R is hydrogen, lower alkyl, lower alkenyl, aryl, aralkyl, lower alkoxy-lower alkyl or certain heterocyclic radicals, or together R and R may form certain heterocyclic radicals
• R is hydrogen, lower alkyl, aryl or certain heterocyclic radicals
• R is lower alkyl, aryl or aralkyl
• X is hydrogen, hydroxy, lower alkanoyloxy, aroyloxy, aralkanoyloxy, the radical of a nitrogen base, a quaternary ammonium radical or together X and R represent a bond linking carbon and oxygen in a lactone
• R represents hydrogen, lower alkyl, aralkyl, a salt forming ion or the group
• R represents lower alkyl, cyclo-lower alkyl, unsaturated cycloalkyl, aryl, aralkyl or a heterocyclic group
• R represents hydrogen, lower alkyl or aryl
• R represents hydrogen, lower alkyl, lower alkenyl, aryl, aralkyl, lower alkoxy-lower alkyl or certain heterocyclic radicals or together R and R may form certain heterocyclic radicals
• R represents hydrogen, lower alkyl, aryl or certain heterocyclic radicals
• R represents lower alkyl, aryl or aralkyl
• X is hydrogen, hydroxy, lower alkanoyloxy, aroyloxy, aralkanoyloxy, the radical of
• R is hydrogen, lower alkyl or alkali metal, especially hydrogen, methyl, pivaloyloxy, sodium or potassium;
• R is phenyl, 1,4-cyclohexadienyl, pyridyl, pyrrolidyl, morpholino, thienyl, furyl, oxazolyl, isoxazolyl, thiazolyl, especially phenyl and most especially 1,4- cyclohexadienyl;
• R and R each is hydrogen or lower alkyl, especially methyl or ethyl;
• R is hydrogen;
• R is hydrogen or lower alkyl, preferably methyl or t-butyl.
• R is preferably hydrogen.
• the lower alkyl groups are straight or branched chain hydrocarbon radicals having one to eight carbons in the chain, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, amyl or the like.
• the lower alkenyl groups are monounsaturated hydrocarbon radicals of the same type, the two to four carbon members being preferred.
• Cycloalkyl groups include cycloaliphatic groups having three to seven carbons in the ring such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl.
• the cyclic groups may also be cycloalkenyl and cycloalkadienyl groups of the same type, e.g., cyclobutenyl, cyclopentenyl, cyclohexenyl, cyclopentadienyl, cy-
• a particularly preferred radical is the l,4-,-cyclohexadienyl group. These may be simply substituted withone to three groups such as halogen, lower alkyl or lower alkoxy.
• the aryl groups are monocyclic carbocyclic aryl groups including simply substituted members.
• this includes the phenyl ring and simply substituted phenyl containing one to three substituents (preferably only one) such as the halogens (chlorine and bromine being preferred), lower alkyl groups such as those defined above, lower alkoxy groups, (i.e., lower alkyl groups of the type defined above attached to an oxygen), hydroxy, lower alkanoyl or lower alkanoyloxy.
• Illustrative are phenyl, 0-, mand pchlorophenyl, o-, mand p-bromophenyl, 3,4- dichlorophenyl, 3,5-dibromophenyl, o-, mand p-tolyl, p-methoxyphenyl, 3,4,5-trimethoxyphenyl and phydroxyphenyl.
• the aralkyl groups include a monocyclic carbocyclic aryl group attached to a lower alkyl group, both as defined above.
• Illustrative are benzyl, o-, mor pchlorobenzyl, o-, m or p-bromobenzyl, o-, mor pmethylbenzyl, phenethyl, p-chlorophenethyl, 3,5- diethylbenzyl, 3,4,5-trichlorobenzyl and the like.
• the lower alkanoyloxy, aroyloxy and aralkanoyloxy groups represented by X include the acyl group of acid esters.
• the lower alkanoyl radicals are the acyl radicals of lower fatty acids containing alkylradicals of the type described above.
• the lower alkanoyloxy groups include, for example, acetoxy, propionyloxy, butyryloxy and the like.
• the aroyloxy groups are derived from monocyclic carbocyclic aryl groups of the kind described.
• the aralkanoyloxy groups consist of monocyclic carbocyclic aryl and alkanoyloxy radicals of the type described.
• X also represents the radical of an amine, e.g., an alkylamine like methylamine, ethylamine, dimethylamine, triethylamine, aralkylamine like dibenzylamine, N,N'-dibenzylpyridinium, pyridinium, l-quinolinium, l-picolinium, etc.
• X and R may also join together, as indicated above to. form a bond linking carbon and oxygen in a lactone ring.
• the heterocyclic groups represented by R R and R.. are pyridyl, pyrrolidyl, morpholinyl, thienyl, furyl, oxazolyl, isoxa zolyl and thiazolyl as well as their simply substituted members wherein the simple substituents are the same as discussed above with respect to the aryl groups.
• the heterocyclic groups represented by the radical are saturated 5- to 6- v membered monocyclic heterocyclic radicals (exclusive hydroxy-lower alkyl (particularly hydroxymethyl and hydroxyethyl) substituted members.
• the salt forming ions may be metal ions, e.g., alumi- R and X have the same meaning described above but especially X is hydrogen or acetoxy, and R is hydrogen or sodium.
• R is hydrogen or a hydroxy, halogen, lower alkyl, lower alkoxy, lower alkanoyl or lower alkanoyloxy group such as those described above.
• R is hydrogen, lower alkyl or lower alkoxy.
• m is l, 2 or 3 and n; isO, l. 2, 3 or 4.
• Most preferred are those compounds wherein R and R each is hydrogen, especially when n is 0.
• R R and R are hydrogen or lower alkyl.
• the compounds of formula I are produced by first forming a compound of the formula wherein hal represents oneof the halogens chlorine, bromine or iodine, preferably bromine and then treating the compound of formula V with an unsubstituted or substituted thiourea of the following formula:
• the compound of formula V is dissolved in an organic solvent at about room temperature and the compound of formula V! is slowly added.
• Suitable solvents include, for example, methanol, ethanol, acetonitrile, dimethylformamide, methylene chloride, chloroform and the like. After a suitable period to allow the reacf tion to come to completion, the nitrogen base is added, then the product may be worked up by conventional techniques,
• R is the acyloxymethyl group this group may be introduced onto the 7-aminocephalosporanic acid moiety either prior to or subsequent to the reaction with the compound of formula VI or Vlll by treatment with one to two moles of a halomethyl ester of the formula wherein hal is halogen, preferably chlorine or bromine, in an inert organic solvent such as dimethylformamide,
• the products of this invention form salts which are also'part of the invention.
• Basic salts form with the acid moiety as-discussed above when the symbol R is hydroand gram negative organisms such as Staphylococcus aureus, Salmonella schottmuelleri, Pseudomonas aeruginosa, Proteus vulgar is, Escherichia cali'and Streptococcus pyogenes. They maybe used as antibacterial agents in a prophylactic manner, e.g., in cleaning or disinfecting compositions, or otherwise to combat infections due to organisms such as those named above, and in general may be utilizedin a manner similar to cephalothin and other cephalosporins.
• a compound of formula I or a physiologically acceptable salt thereof may be used in various animal species in an amount of about l to 200 mg./kg., daily, orally or parenterally, in single or two to four divided doses to treat infections of bacterial origin, e.g., 5.0 mg./kg. in mice.
• a compound of formula l or a physiologically acceptable salt thereof may be incorporated in an oral dosage form such as tablets, capsules or elixirs or in an injectable form in a sterile aqueous vehicle prepared according to conventional pharmaceutical practice.
• compositions may also be used in cleaning or disinfecting compositions, e.g., for cleaning barns or dairy equipment, at a concentration of about 0.1 to 1 percent by weight of such compounds admixed with, suspended or dissolved in conventional inert dry or aqueous carriers for application by washing or spraying.
• EXAMPLE 2 7-[2-(methylamidinothio)-2-phenylacetamidolcephalosporanic acid 2.34 g. of 7-(a-bromophenylacetamido)cephalosporanic acid and 0.45 g. of methylthiourea are reacted for 2 hours at --20 according to the procedure of Example phenylacetamido]cephalosporanic acid.
• R is hydrogen, lower alkyl, alkali metal or R is lower alkyl, phenyl, cyclohexadienyl, thienyl or furyl; R and R each is hydrogen, lower alkyl or phenyl; R is hydrogen, lower alkyl, lower alkenyl or phenyl; R is lower alkyl, phenyl or phenyl-lower alkyl; and X is hydrogen or lower alkanoyloxy.
• R is 1,4- cyclohexadienyl and R R R and X each is hydrogen.
• R is hydrogen or alkali metal; R and R each is hydrogen or lower alkyl; R is hydrogen, lower alkyl or lower alkenyl; R is hydrogen, lower alkyl or lower alkoxy; X is hydrogen or acetoxy; and n is 0 to 4.
• R is hydrogen, lower alkyl or lower alkoxy.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Cephalosporin Compounds (AREA)
• Fodder In General (AREA)

Priority Applications (7)

Applications Claiming Priority (1)

Publications (1)

Family

ID=22722880

Family Applications (1)

Country Status (7)

Cited By (7)

Families Citing this family (1)

Citations (3)

• 1971
  • 1971-11-04 US US00195805A patent/US3839329A/en not_active Expired - Lifetime
• 1972
  • 1972-11-01 CA CA155,350A patent/CA982552A/en not_active Expired
  • 1972-11-02 DE DE2253800A patent/DE2253800A1/de active Pending
  • 1972-11-02 GB GB5061372A patent/GB1413175A/en not_active Expired
  • 1972-11-02 JP JP47110206A patent/JPS4856694A/ja active Pending
  • 1972-11-03 CH CH1606772A patent/CH553820A/fr not_active IP Right Cessation
  • 1972-11-03 FR FR7239013A patent/FR2158509B1/fr not_active Expired

Patent Citations (3)

Also Published As

Similar Documents